Skip to main content

Oncorus, Inc.

ONCRDelisted Jul 10, 2023
Industry
Pharmaceutical Preparations
SEC CIK
0001671818

Oncorus, Inc. was delisted on Jul 10, 2023; its insiders filed their last Form 4 on Dec 30, 2022; 32 institutions reported holding it in 13F filings for Q1 2023, worth $3.78M in total; no superinvestor held it.

13F holders, Q3 2022

Institutional positions in Oncorus, Inc. as of Sep 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
40
−5 vs. Q2 2022
Shares held
16.5M
−455.7K (−2.7%) vs. Q2 2022
Total value
$14.1M
−$7.36M (−34.4%) vs. Q2 2022
New holders
3
6 more added
Sold out
8
18 more reduced

Compare with Q2 2022: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting ONCR on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ3 2022: 40 institutions
Q1 2021: 57 institutionsQ2 2021: 50 institutionsQ3 2021: 48 institutionsQ4 2021: 56 institutionsQ1 2022: 56 institutionsQ2 2022: 45 institutionsQ3 2022: 40 institutionsQ4 2022: 33 institutionsQ1 2023: 32 institutionsQ2 2023: 4 institutionsQ3 2023: 1 institutionQ4 2023: 0 institutionsQ1 2024: 0 institutionsQ2 2024: 0 institutionsQ3 2024: 0 institutionsQ4 2024: 0 institutionsQ1 2025: 0 institutionsQ2 2025: 0 institutionsQ3 2025: 0 institutionsQ4 2025: 0 institutionsQ1 2026: 0 institutionsQ2 2026: 0 institutions
Value heldQ3 2022: $14.1M
Q1 2021: $278.2MQ2 2021: $282.6MQ3 2021: $186.2MQ4 2021: $107.1MQ1 2022: $34.5MQ2 2022: $21.4MQ3 2022: $14.1MQ4 2022: $3.95MQ1 2023: $3.78MQ2 2023: $212.1KQ3 2023: $3Q4 2023: $0Q1 2024: $0Q2 2024: $0Q3 2024: $0Q4 2024: $0Q1 2025: $0Q2 2025: $0Q3 2025: $0Q4 2025: $0Q1 2026: $0Q2 2026: $0
Institutions holding ONCR and their total value by quarter
QuarterHoldersValue
Q2 20260$0
Q1 20260$0
Q4 20250$0
Q3 20250$0
Q2 20250$0
Q1 20250$0
Q4 20240$0
Q3 20240$0
Q2 20240$0
Q1 20240$0
Q4 20230$0
Q3 20231$3
Q2 20234$212.1K
Q1 202332$3.78M
Q4 202233$3.95M
Q3 202240$14.1M
Q2 202245$21.4M
Q1 202256$34.5M
Q4 202156$107.1M
Q3 202148$186.2M
Q2 202150$282.6M
Q1 202157$278.2M

Institutions, Q3 2022

Shares, value and share of portfolio for each institution holding Oncorus, Inc.; share changes are against Q2 2022.

Institutions holding ONCR in Q3 2022
InstitutionSharesValue% of portfolioChange in sharesAction
Deerfield Management Company, L.P. (Series C)3,148,977$2.68M0.05%00.0%Unchanged
MPM Asset Management LLC2,849,464$2.42M0.92%00.0%Unchanged
MPM Oncology Impact Management LP2,377,031$2.02M0.48%00.0%Unchanged
CHI Advisors LLC2,367,436$2.01M0.54%00.0%Unchanged
Citadel Advisors LLC1,914,594$1.63M0.00%+23,002+1.2%Added
Fosun International Ltd962,323$818.0K0.15%00.0%Unchanged
Sphera Funds Management Ltd.540,258$459.0K0.08%00.0%Unchanged
Vanguard Group Inc496,314$422.0K0.00%−56,326−10.2%Reduced
Millennium Management LLC368,026$313.0K0.00%−9,706−2.6%Reduced
BlackRock Inc.272,364$231.0K0.00%−6,376−2.3%Reduced
Renaissance Technologies LLC209,533$178.0K0.00%−7,917−3.6%Reduced
Geode Capital Management, LLC138,226$117.0K0.00%00.0%Unchanged
We Are One Seven, LLC116,389$98.0K0.01%00.0%Unchanged
Two Sigma Advisers, LP108,100$92.0K0.00%−42,600−28.3%Reduced
Ergoteles LLC86,135$73.0K0.00%−12,465−12.6%Reduced
Two Sigma Investments, LP81,492$69.0K0.00%−19,500−19.3%Reduced
State Street Corp70,135$60.0K0.00%00.0%Unchanged
Bridgeway Capital Management, LLC67,300$57.0K0.00%−16,000−19.2%Reduced
Bank of New York Mellon Corp66,995$57.0K0.00%−300.0%Reduced
Letko, Brosseau & Associates Inc59,150$50.0K0.00%00.0%Unchanged
Sawtooth Solutions, LLC36,748$31.0K0.00%−40,588−52.5%Reduced
SG Americas Securities, LLC36,337$31.0K0.00%+23+0.1%Added
Northern Trust Corp28,960$24.0K0.00%00.0%Unchanged
HSBC Holdings PLC26,420$22.0K0.00%00.0%Unchanged
Goldman Sachs Group Inc24,411$21.0K0.00%−93,514−79.3%Reduced
Morgan Stanley15,389$13.0K0.00%−28,109−64.6%Reduced
Qube Research & Technologies Ltd15,874$13.0K0.00%−2,000−11.2%Reduced
Assenagon Asset Management S.A.13,642$12.0K0.00%+13,642New
Bank of America Corp12,762$11.0K0.00%−18,358−59.0%Reduced
Barclays PLC10,361$9.00K0.00%−639−5.8%Reduced
Tower Research Capital LLC (TRC)11,157$9.00K0.00%+2,855+34.4%Added
UBS Group AG3,604$3.00K0.00%−4,412−55.0%Reduced
JPMorgan Chase & Co1,306$1.00K0.00%+310+31.1%Added
BNP Paribas Arbitrage, SA905$7690.00%+905New
Citigroup Inc491$00.00%−1,635−76.9%Reduced
FMR LLC83$00.00%−663−88.9%Reduced
Wells Fargo & Company129$00.00%+16+14.2%Added
Royal Bank of Canada225$00.00%+95+73.1%Added
Your Advocates Ltd., LLP100$00.00%00.0%Unchanged
China Universal Asset Management Co., Ltd.243$00.00%+243New
Private Advisor Group, LLC0$00.00%−81,304−100.0%Sold out
Susquehanna International Group, LLP0$00.00%−41,192−100.0%Sold out
Cubist Systematic Strategies, LLC0$00.00%−10,868−100.0%Sold out
Legal & General Group Plc0$00.00%−1,629−100.0%Sold out
New York State Common Retirement Fund0$00.00%−203−100.0%Sold out
Credit Suisse AG0$00.00%−11−100.0%Sold out
Simplex Trading, LLC0$00.00%−605−100.0%Sold out
Capital Advisors, Ltd. LLC0$00.00%−121−100.0%Sold out